Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.
Trial details
- Registry ID
- NCT04925024
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.NCT04925024 | LGVN | Phase 2 | Active not recruiting | 2026-06-30Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |